In breast cancer cell lines, experimental activation of Stat5 promotes differentiation, inhibits invasive characteristics [20-22], and blocks progesterone-induced emergence of a drug-resistant CK5-positive cell population [23] with tumor-initiating characteristics [24-26]. Here, STAT5B is linked to breast cancer.